Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) closed at $17.50 in the last session, down -3.21% from day before closing price of $18.08. In other words, the price has decreased by -$3.21 from its previous closing price. On the day, 0.57 million shares were traded. CNTA stock price reached its highest trading level at $17.9 during the session, while it also had its lowest trading level at $16.83.
Ratios:
We take a closer look at CNTA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 21.52 and its Current Ratio is at 21.52. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on September 20, 2024, Upgraded its rating to Overweight and sets its target price to $26 from $11 previously.
On September 19, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $33.
On July 18, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $14.Oppenheimer initiated its Outperform rating on July 18, 2024, with a $14 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 13 ’24 when SAHA SAURABH bought 32,023 shares for $18.28 per share.
Weinhoff Gregory M sold 11,742 shares of CNTA for $180,628 on Oct 25 ’24. The Chief Business Officer now owns 183,266 shares after completing the transaction at $15.38 per share. On Oct 25 ’24, another insider, Weinhoff Gregory M, who serves as the Officer of the company, bought 11,742 shares for $15.57 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTA now has a Market Capitalization of 2307287552 and an Enterprise Value of 1591694336. For the stock, the TTM Price-to-Sale (P/S) ratio is 286.64 while its Price-to-Book (P/B) ratio in mrq is 4.62. Its current Enterprise Value per Revenue stands at 232.262 whereas that against EBITDA is -9.868.
Stock Price History:
Over the past 52 weeks, CNTA has reached a high of $18.74, while it has fallen to a 52-week low of $5.58. The 50-Day Moving Average of the stock is 10.29%, while the 200-Day Moving Average is calculated to be 50.44%.
Shares Statistics:
According to the various share statistics, CNTA traded on average about 639.78K shares per day over the past 3-months and 596830 shares per day over the past 10 days. A total of 98.77M shares are outstanding, with a floating share count of 79.98M. Insiders hold about 29.33% of the company’s shares, while institutions hold 51.24% stake in the company. Shares short for CNTA as of 1730332800 were 2147348 with a Short Ratio of 3.36, compared to 1727654400 on 1956095. Therefore, it implies a Short% of Shares Outstanding of 2147348 and a Short% of Float of 2.0599999.
